Drug-eluting stents: a systematic review and economic evaluation
Hill RA, Boland A, Dickson R, Dundar Y, Haycox A, McLeod C, Mujica Mota R, Walley T, Bagust A
Record ID 32007000633
English
Authors' objectives:
"The objectives were to assess the effectiveness and cost-effectiveness of the use of drug-eluting coronary artery stents in percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD).
Specifically, the clinical review compares the use of: drug-eluting stents (DES) versus non-drug-eluting bare metal stents (BMS) drug-eluting stents of different design (DES versus DES).
A technology assessment was completed in 2003, early in the introduction of DES. Continued, rapid development of DES suggests that it is appropriate to explore the current evidence base on DES in order to inform the development of National Institute for Health and Clinical Excellence (NICE) guidance for the NHS in England and Wales." (from executive summary)
Authors' recommendations:
The conclusions of the assessment are that the use of DES would be best targeted at the subgroups of patients with the highest risks of requiring reintervention, and could be considered cost-effective in only a small percentage of such patents. This is similar to the conclusion of our previous assessment.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Stents
- Coronary Disease
- Myocardial Ischemia
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO